Table 3.
Univariate survival statistics – positive node patients
| III-A. Univariate survival – patient characteristics | Median (months) | 3 Yr (%) | 5 Yr (%) | p |
|---|---|---|---|---|
| Overall survival | ||||
| n = 160 | 15.4 | 16.6 | 4.6 | |
| Univariate demographics | ||||
| AGE (10 years), HR (95% CI) | 1.34 (1.19, 1.57) | <0.0001 | ||
| Gender | 0.1641 | |||
| Male | 17.5 | 16.2 | 3.0 | |
| Female | 11.7 | 16.9 | 6.1 | |
| Comorbidities | 0.5284 | |||
| None | 18.0 (13.5, 21.5) | 14.5 | 3.9 | |
| One or more | 9.3 (3.3, 21.4) | 10.0 | 10.0 | |
| III-B. Univariate tumor characteristics | Median (months) | 3 Yr (%) | 5 Yr (%) | p |
| Grade | 0.9956 | |||
| 1–2 | 14.2 | 16.7 | 6.8 | |
| 3–4 | 16.6 | 15.7 | 1.9 | |
| Surgical margin | 0.3986 | |||
| Negative | 18.3 | 18.8 | 4.7 | |
| Micro or macro positive | 10.4 | 13.3 | 4.4 | |
| Involved – not specified | 11.8 | 17.2 | 8.6 | |
| Regional nodes examined | 0.7122 | |||
| 0 | – | – | – | |
| 1–3 | 11.7 | 16.6 | 7.2 | |
| ≥4 | 63.4 | 1.7 | 0.0 | |
| Lymph nodes positive | 0.3613 | |||
| 0 | – | – | – | |
| 1–3 | 15.0 | 18.1 | 5.8 | |
| 4–11 | 15.4 | 10.5 | 0.0 | |
| Tumor size | 0.0488 | |||
| <5 cm | 18.23 | 25.3 | 12.6 | |
| ≥5 cm | 15.0 | 13.4 | 2.2 | |
| III-C. Univariate – operative outcome | Median (months) | 3 Yr (%) | 5 Yr (%) | p |
| Length of stay (10 fold increase), HR (95% CI) | 1.29 (0.5, 3.1) | 0.5613 | ||
| Readmission 30 days | 0.5376 | |||
| None | 17.7 | 15.2 | 5.3 | |
| Readmission | 15.5 | 0.0 | 0.0 | |
| III-D. Univariate adjuvant therapy | Median (months) | 3 Yr (%) | 5 Yr (%) | p |
| Systemic treatment | 0.0033 | |||
| Chemotherapy only | 19.1 | 23.2 | 2.9 | |
| Chemotherapy and radiation | 20.1 | 31.0 | 12.1 | |
| None | 9.3 | 10.2 | 3.4 | |
Missing data reported in Table 1. Kaplan–Meier curves of categorical variables compared with log rank test of homogeneity or trend test for 3 or more ordered levels. Continuous variables tested with Cox proportion hazards regression. HR, hazard ratio.